This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: Lou Vaickus: Innovator in Immunoregulation
Introduction
Lou Vaickus is a notable inventor based in Hingham, MA (US). She has made significant contributions to the field of immunology, particularly through her innovative patents. With a total of 2 patents, her work focuses on the development of anti-ILT5 antibodies and their applications in treating various diseases.
Latest Patents
Lou Vaickus's latest patents include groundbreaking methods for using anti-ILT5 antibodies and ILT5-binding fragments. These methods aim to induce an immunostimulatory effect in T cells when they interact with antigen presenting cells (APCs) previously contacted with the anti-ILT5 antibody or its fragments. Additionally, her patents disclose techniques to inhibit T cell responses, such as pro-liferative responses, when these cells are concomitantly contacted with an APC that has also been engaged with the anti-ILT5 antibody or fragment. These innovations hold promise for enhancing immunotherapy and developing new treatment strategies.
Career Highlights
Lou Vaickus is currently associated with Merck Sharp & Dohme Corp., where she continues to advance her research in immunoregulation. Her work has positioned her as a key figure in the development of immunostimulatory adjuvants, contributing to the broader field of immunotherapy.
Collaborations
Throughout her career, Lou has collaborated with esteemed colleagues, including Michael Rosenzweig and Joe Ponte. These partnerships have facilitated the exchange of ideas and fostered innovation in her research endeavors.
Conclusion
Lou Vaickus is a pioneering inventor whose work in immunoregulation is paving the way for new therapeutic approaches. Her contributions to the field are significant and continue to impact the landscape of immunology.